source Post navigation APhA 2025: GLP-1 Receptor Agonists vs SGLT2 Inhibitors Show Varied Benefit for Cardiovascular Outcomes in Patients With Diabetes – Pharmacy Times Low-glucose alerts beneficial for insulin-treated drivers with diabetes – Medical Xpress